Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  doxorubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 2360 for your search:
Start Over
Prevention of CHOP-induced Chronic Cardiotoxicity
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 15 to 70
Sponsor: Other
Protocol IDs: OLSG-0401, NCT00162955
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 45
Sponsor: Other
Protocol IDs: 0501-37, NCT00352872
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 1. NHL, non, NCT00969462
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: RJ-2010-56, NCT01358253
Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CHOP-Z, NCT01418430
Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3278
Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
Phase II-III Chemotherapy with Hexamethylmelamine and L-Phenylalanine Mustard for Stage III and IV Ovarian Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75118
Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
Phase II-III HMM vs FAC (5-FU/ADR/CTX) Chemotherapy for Advanced Transitional Cell Bladder Cancer with Impaired Renal Function
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7904
Phase II-III Chemotherapy with CAP (CTX/ADR/CACP) vs AMSA for Advanced Transitional Cell Cancer of the Urinary Bladder (Summary Last Modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7922
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
Phase II/III Chemotherapy with CTX/ADR/5-FU/MTX with and without Cell Synchronization with Tamoxifen and Premarin for Metastatic Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: NCI-76-C-377A, NCI-MB-160A
Phase II/III Chemotherapy with CTX/ADR/MTX/5-FU, with vs without Hormonal Synchronization with TMX/Premarin, for Metastatic Mammary Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-76-C-377B, NCI-MB-160B
Phase II/III Evaluation of Intraoperative Radiotherapy and Adjuvant Chemotherapy with CAM (CTX/ADR/MTX) for Nonmetastatic Soft Tissue Retroperitoneal Sarcoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 10 to 65
Sponsor: NCI
Protocol IDs: NCI-80-C-45, NCI-SB-S9, NCI-T83-1103N, T83-1103
Phase II/III Adjuvant ADR/CTX Followed by High-Dose MTX vs ADR/CTX Alone, with Radiotherapy in Selected Cases, for Histologic Grade II/III Soft Tissue Sarcoma of an Extremity
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-100
Phase II/III Chemotherapy with SZC/5-FU vs ADR/5-FU for Unresectable Carcinoid Tumors, with DTIC for Failures (Summary Last Modified 07/89)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1281
Start Over